News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 1
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
CPHI Milan Names 2026 Pharma Awards Finalists
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
5